Mr. Wei Zhang is the Chief Operations Officer at Tavotek Biotherapeutics. Before joining Tavotek, he was the Head of Digital Health and Information Technology at the Johnson and Johnson (J&J) Asia Pacific Innovation Center. While at J&J, he worked extensively with the global therapeutic team to identify and explore novel ideas and concepts from external partners to facilitate new business opportunities. The scope of his work included Big Data, Artificial Intelligence for drug development, business intelligence, robotic technology, etc. Before his career at J&J, Mr. Zhang was a successful serial entrepreneur and co-founded Chance Share Consultant Company which provided pharmaceutical consulting services to major Big Pharma players such as Bayer, Sanofi, and MSD. He oversaw and managed operational processes to ensure excellent customer experience. In addition, his role at Chance Share included optimizing the company's operating capabilities, business strategies, along with financial policies and procedures. Under his tenure at Chance Share, business grew rapidly and successfully.
Prior to his entrepreneurial period, Mr. Zhang was an Information Technology Business Partner of the global conglomerate Unilever for more than 13 years. His role at Unilever included serving as the strategic interface with assigned business units and various functional areas in business technology strategy development, solution discovery, and operation management. He provided important strategic consulting support and advice through various critical Information Technology initiatives for the company. His work at Unilever also included sharingknowledge of technology opportunities to build competitive advantage to improve efficiency and effectiveness of business units.
Mr. Zhang has extensive training in Information Technology and received his master’s degree in computer science from Fudan University. His extensive experience in partnering with many business and key stakeholders are invaluable to the success of business operations in Tavotek.
Copyright © 2020 Tavotek Biotherapeutics - All Rights Reserved.